SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.

Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.

SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.

Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.

Obtenga más información AQUI

December 17, 2025

Action Required: Clinical Laboratory Improvement Amendment (CLIA) Revalidation in Provider Enrollment and Management System (PEMS)

December 9, 2025

Updated Texas Health Steps Quick Reference Guide Now Available

December 5, 2025

Age Restriction Update for Procedure Code J2781

HHSC to Remove Oxbryta Products from all Formularies as of Oct. 17, 2024

Date: October 4, 2024
Attention: Providers
Effective date: October 10, 2024

Call to action: On September 25, 2024, Pfizer, the manufacturer voluntarily recalled all Oxbryta® (voxelotor) products from worldwide markets due to safety concerns.

Oxbryta will no longer be a covered benefit and will no longer be on the formulary starting October 17, 2024.

Product	NDC No.
OXBRYTA 500 MG TABLET	72786010101
OXBRYTA 300 MG TABLET FOR SUSP	72786011102
OXBRYTA 300 MG TABLET FOR SUSP	72786011103
OXBRYTA 300 MG TABLET	72786010202
OXBRYTA 300 MG TABLET	72786010203

Next step for Providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.